Bryce Binstadt, MD, PhD
University of Minnesota
Innovation Research Award
A Novel TNFR1-Selective Small Molecule Inhibitor to Treat Rheumatoid ArthritisArthritis is the swelling and tenderness of one or more joints. Learn more. and Related Inflammatory Diseases
Dr. Binstadt and his collaborators are developing rheumatoid arthritisThe most common autoimmune type of arthritis. In RA, your body’s immune system begins to react against its own tissues, causing significant inflammation in your... therapies that can be taken orally rather than injections and may have potentially fewer side effects than the current therapies.
“Our project has the potential to change therapies for patients with rheumatoid arthritisThe most common autoimmune type of arthritis. In RA, your body’s immune system begins to react against its own tissues, causing significant inflammation in your... and other inflammatoryInflammation is a normal part of the body’s defense to injury or infection, and, in this way, it is beneficial. But inflammation is damaging when... diseases in the future.”
To hear more from Dr. Binstadt, watch the video above.
****
Donors like you make our important research funding possible. Consider donating today.